Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 23.919% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CC(C)c1ccc(/C=N/n2cnnc2)cc1
[b] O=C1NC[C@H](c2ccccc2)N(CCC23CC4CC(CC(C4)C2)C3)C1=O
Answer: b. O=C1NC[C@H](c2ccccc2)N(CCC23CC4CC(CC(C4)C2)C3)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1NC[C@H](c2ccccc2)N(CCC23CC4CC(CC(C4)C2)C3)C1=O
O=C1NC[C@H](c2ccccc2)N(CCC23CC4CC(CC(C4)C2)C3)C1=O
(6S)-1-[2-(1-adamantyl)ethyl]-6-phenylpiperazine-2,3-dione